Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3565

Novartis to buy Regulus Therapeutics for up to $1.7B

$
0
0
Novartis plans to acquire Regulus Therapeutics for $7.00 per share in cash, or $800 million, the microRNA specialist said Wednesday. This is more than double Regulus’ share price at Tuesday’s close ...

Viewing all articles
Browse latest Browse all 3565

Trending Articles